Azithromycin use for common acute respiratory infections during a  Mycoplasma pneumoniae national surge: results from the SHARPS-OP benchmarking collaborative

Key Points

• To analyze azithromycin use for respiratory infections coinciding with a Mycoplasma pneumoniae surge.
• Benchmarking collaborative data analysis across multiple sites.
• Assessment of azithromycin prescribing practices during national rise in Mycoplasma pneumoniae cases.
• Increased azithromycin prescriptions noted during Mycoplasma pneumoniae surge.
• Findings may indicate trends in treatment choices for acute respiratory infections.